These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32510704)

  • 21. Altered distribution and enhanced osteoclastogenesis of mucosal-associated invariant T cells in gouty arthritis.
    Cho YN; Jeong HS; Park KJ; Kim HS; Kim EH; Jin HM; Jung HJ; Ju JK; Choi SE; Kang JH; Park DJ; Kim TJ; Lee SS; Kee SJ; Park YW
    Rheumatology (Oxford); 2020 Aug; 59(8):2124-2134. PubMed ID: 32087015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quantitative determination of HBsAg in blood sera and hepatitis B virus covalently closed circular DNA in liver tissue as markers of chronic viral hepatitis B activity].
    Semenov AV; Vlasova IA; Ostankova IuV; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):55-61. PubMed ID: 24738295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection.
    Khlaiphuengsin A; Chuaypen N; Sodsai P; Reantragoon R; Han WM; Avihingsanon A; Tangkijvanich P
    PLoS One; 2020; 15(12):e0244112. PubMed ID: 33382729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DR
    Tian L; Xu J; Chen C; Lin J; Ju L; Chen L; Zhang Y; Han X; Liu L
    Scand J Immunol; 2023 Sep; 98(3):e13286. PubMed ID: 37163215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis.
    Beudeker BJB; van Oord GW; Arends JE; Schulze Zur Wiesch J; van der Heide MS; de Knegt RJ; Verbon A; Boonstra A; Claassen MAA
    Liver Int; 2018 Mar; 38(3):458-468. PubMed ID: 28792648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection.
    Schuch A; Zecher BF; Müller PA; Correia MP; Daul F; Rennert C; Tauber C; Schlitt K; Boettler T; Neumann-Haefelin C; Hengel H; Pircher H; Cerwenka A; Thimme R; Hofmann M
    J Hepatol; 2019 Mar; 70(3):351-360. PubMed ID: 30342116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent activation.
    Loh L; Wang Z; Sant S; Koutsakos M; Jegaskanda S; Corbett AJ; Liu L; Fairlie DP; Crowe J; Rossjohn J; Xu J; Doherty PC; McCluskey J; Kedzierska K
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10133-8. PubMed ID: 27543331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
    Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
    PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic viral infection compromises the quality of circulating mucosal-invariant T cells and follicular T helper cells via expression of both activating and inhibitory receptors.
    Vimali J; Yong YK; Murugesan A; Tan HY; Zhang Y; Ashwin R; Raju S; Balakrishnan P; Larsson M; Velu V; Shankar EM
    Res Sq; 2023 Apr; ():. PubMed ID: 37163092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation and Impaired Tumor Necrosis Factor-α Production of Circulating Mucosal-Associated Invariant T Cells in Patients with Trauma.
    Jo YG; Jin HM; Cho YN; Kim JC; Kee SJ; Park YW
    J Innate Immun; 2019; 11(6):506-515. PubMed ID: 31085907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells.
    Tang XZ; Jo J; Tan AT; Sandalova E; Chia A; Tan KC; Lee KH; Gehring AJ; De Libero G; Bertoletti A
    J Immunol; 2013 Apr; 190(7):3142-52. PubMed ID: 23447689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
    Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
    Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.
    Kammann T; Gorin JB; Parrot T; Gao Y; Ponzetta A; Emgård J; Maleki KT; Sekine T; Rivera-Ballesteros O; ; Gredmark-Russ S; Rooyackers O; Skagerberg M; Eriksson LI; Norrby-Teglund A; Mak JYW; Fairlie DP; Björkström NK; Klingström J; Ljunggren HG; Aleman S; Buggert M; Strålin K; Sandberg JK
    J Immunol; 2024 Feb; 212(3):389-396. PubMed ID: 38117799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-1-expressing MAIT cells from patients with tuberculosis exhibit elevated production of CXCL13.
    Jiang J; Cao Z; Qu J; Liu H; Han H; Cheng X
    Scand J Immunol; 2020 Apr; 91(4):e12858. PubMed ID: 31833092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic analysis of mucosal-associated invariant T cells in haematological malignancies.
    Bacova B; Cierny J; Nemcekova L; Smetanova/Brozova J; Novak J
    Scand J Immunol; 2024 Jun; 99(6):e13364. PubMed ID: 38720521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.
    Li M; Zhou ZH; Sun XH; Zhang X; Zhu XJ; Jin SG; Jiang Y; Gao YT; Li CZ; Gao YQ
    Hepatol Int; 2016 Jul; 10(4):594-601. PubMed ID: 26924524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.
    Paquin-Proulx D; Greenspun BC; Costa EA; Segurado AC; Kallas EG; Nixon DF; Leal FE
    PLoS One; 2017; 12(4):e0175345. PubMed ID: 28384290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-resident mucosal-associated invariant T (MAIT) cells in the human kidney represent a functionally distinct subset.
    Terpstra ML; Remmerswaal EBM; van der Bom-Baylon ND; Sinnige MJ; Kers J; van Aalderen MC; Geerlings SE; Bemelman FJ
    Eur J Immunol; 2020 Nov; 50(11):1783-1797. PubMed ID: 32652598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal-Associated Invariant T Cell Features and TCR Repertoire Characteristics During the Course of Multiple Sclerosis.
    Carnero Contentti E; Farez MF; Correale J
    Front Immunol; 2019; 10():2690. PubMed ID: 31824489
    [No Abstract]   [Full Text] [Related]  

  • 40. Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease.
    Juno JA; Waruk JLM; Wragg KM; Mesa C; Lopez C; Bueti J; Kent SJ; Ball TB; Kiazyk SA
    Front Immunol; 2018; 9():1076. PubMed ID: 29868028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.